Search hospitals > Michigan > Trenton
Henry Ford Cancer Institute-Downriver
Claim this profileTrenton, Michigan 48183
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Squamous Cell Carcinoma
Conducts research for Tumors
120 reported clinical trials
4 medical researchers
Summary
Henry Ford Cancer Institute-Downriver is a medical facility located in Trenton, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Squamous Cell Carcinoma, Tumors and other specialties. Henry Ford Cancer Institute-Downriver is involved with conducting 120 clinical trials across 327 conditions. There are 4 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Thomas J. Doyle.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
PR positive
Top PIs
Ding WangHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Non-Small Cell Lung Cancer
49 reported clinical trials
116 drugs studied
Haythem Y. AliHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
39 reported clinical trials
103 drugs studied
Eleanor M. WalkerHenry Ford Hospital2 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
18 reported clinical trials
58 drugs studied
Thomas J. DoyleHenry Ford Cancer Institute¿Downriver11 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Henry Ford Cancer Institute-Downriver
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Cancer
Bladder Carcinoma
Lung Cancer
Prostate Cancer
Renal Cell Carcinoma
Breast Cancer
Urothelial Carcinoma
Reduced-Intensity Chemoradiation
for Anal Cancer
This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy with radiation therapy may kill more tumor cells. This study may help doctors find out if lower-dose chemoradiation is as effective and has fewer side effects than standard-dose chemoradiation, which is the usual approach for treatment of this cancer type.
Recruiting3 awards Phase 25 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Henry Ford Cancer Institute-Downriver?
Henry Ford Cancer Institute-Downriver is a medical facility located in Trenton, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Squamous Cell Carcinoma, Tumors and other specialties. Henry Ford Cancer Institute-Downriver is involved with conducting 120 clinical trials across 327 conditions. There are 4 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Thomas J. Doyle.